IL22 and cystic fibrosis: Further, in the CF mouse we have demonstrated significant elevations in serum levels of novel proinflammatory cytokines IL-17α and MIP-3α, and novel pleiotropic, general markers of inflammation MIP-2, IL-27p28, IP-10, IL-16, and IL-22.